Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00437580
Status:
UNKNOWN
Last Update Posted:
2011-01-19
First Post:
2007-02-19
Brief Title:
Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage
Sponsor:
University Hospital Clermont-Ferrand
Organization:
University Hospital Clermont-Ferrand
Study Overview
Official Title:
Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus VRE Intestinal Carriage a Double Blind Randomized Pilot Study
Status:
UNKNOWN
Status Verified Date:
2011-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to reduce the duration of VRE intestinal carriage by the administration of Lactobacillus casei rhamnosus strain Lcr 35 LC Patients will be blindly randomized to be assigned to a 5 weeks regimen with the probiotic 10 9 lactobacillus bid or to a 5 weeks regimen with placeboA stool culture will be performed every week for 5 weeks during the administration of treatment then every two weeks until 3 consecutive negative stool culture for VRE
Detailed Description:
This study aims to reduce the duration of VRE intestinal carriage by the administration of Lactobacillus casei rhamnosus strain Lcr 35 LC Patients will be blindly randomized to be assigned to a 5 weeks regimen with the probiotic 10 9 lactobacillus bid or to a 5 weeks regimen with placeboA stool culture will be performed every week for 5 weeks during the administration of treatment then every two weeks until 3 consecutive negative stool culture for VRE
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None